Today GSK launches its public health campaign, “Ask2BSure,” to encourage parents to talk with their child’s doctor to be sure if they have received meningitis B vaccination.
- Actor, director, writer and mother of four Soleil Moon Frye partners with GSK on campaign
|
| [26-August-2021] |
|
PHILADELPHIA, Aug. 26, 2021 /PRNewswire/ -- Today GSK launches its public health campaign, "Ask2BSure," to encourage parents to talk with their child's doctor to be sure if they have received meningitis B vaccination. The campaign is launching at a critical time for vaccination, when a large portion of teens and young adults may be unvaccinated against meningitis B. According to CDC data, coverage with at least 1 dose of meningitis B vaccination was low, at 21.8% among adolescents aged 17 years in 2019.1 Meningococcal disease, commonly referred to as meningitis, is an uncommon, but potentially life-threatening illness.2 Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8857131-gsk-ask2bsure-meningitis-b-vaccination/ To help kick-off the campaign, actor, producer, director and mother of four Soleil Moon Frye, whose credits include Punky Brewster and kid90, has partnered with GSK to share her perspective as her oldest daughter, Poet, turns 16 and they navigate the meningitis B vaccination discussion with their pediatrician. "I have four children, and they are my whole world. Like all moms, I want to help keep my kids healthy, and vaccinations are one of the ways I've tried to do that. I always ask a lot of questions and do my research, so I was surprised when I only recently learned about meningitis B," said Frye. "My daughter Poet turned 16 this week, an important milestone but also one relevant to meningitis B vaccination. While many of our kids have received a meningitis vaccine when they were younger, they could miss vaccination for meningitis B. It's important to me to help other parents start this conversation with their child's doctors—because as parents we want to do everything we can to help protect our children, including from vaccine-preventable diseases." CDC currently recommends meningitis B vaccination for teens and young adults aged 16-23 years (preferred ages 16-18), based on 'shared clinical decision-making', a decision process between the health care provider and the patient or parent/guardian.3 "Ask2BSure" was created to educate and empower parents to start the meningitis B vaccination discussion with their child's doctor. "Like Soleil, parents may not know there are two different types of vaccinations recommended for young adults to help protect against the five vaccine-preventable groups of meningitis, one for groups A, C, W and Y, and another for group B,4" said Dr. Leonard Friedland, VP, Director of Scientific Affairs and Public Health, GSK Vaccines. "As parents catch up on wellness visits and vaccination for their children, it is important to ask their child's doctor if they might be missing meningitis B vaccination." To commemorate the "Ask2BSure" campaign launch, GSK has pledged to donate $1 for every unique view of the campaign video (up to $10,000) to the Meningitis B Action Project, a joint initiative of the Kimberly Coffey Foundation and the Emily Stillman Foundation. The Project was started by two mothers who each lost their daughters to meningitis B and are now on a mission to educate parents, young adults and healthcare providers about meningitis B and vaccinations to help prevent it. Views for the donation will be counted for up to 3 months following the launch. Parents should start the conversation with their child's doctor to Ask2BSure if they have received meningitis B vaccination. Visit Ask2Bsure.com for more information. About Meningitis About Ask2BSure About GSK
1 National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2019. 2020; 69(33). Morbidity and Mortality Weekly Report. https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6933-H.pdf. Reviewed August 21, 2020. Accessed August 2021. 
SOURCE GSK |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
View original content:
